Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 34 (4), 688-700
- https://doi.org/10.1038/s41379-020-00701-w
Abstract
No abstract availableKeywords
Funding Information
- MEXT | Japan Society for the Promotion of Science (17K15659)
This publication has 51 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic GliomaClinical Cancer Research, 2012
- The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomasHistopathology, 2012
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspectiveActa Neuropathologica, 2010
- FISH assay development for the detection ofp16/CDKN2Adeletion in malignant pleural mesotheliomaJournal of Clinical Pathology, 2010
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Multiplex Ligation-Dependent Probe AmplificationThe Journal of Molecular Diagnostics, 2006
- Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesionLaboratory Investigation, 2005